Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not ...

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate ...